BL-8040, a peptidic CXCR4 antagonist, induces leukemia cell death and specific leukemia cell mobilization in relapsed/refractory acute myeloid leukemia patients in an ongoing phase IIA clinical trial Meeting Abstract
| Authors: | Borthakur, G.; Nagler, A.; Ofran, Y.; Rowe, J. M.; Altman, J. K.; Frankfurt, O.; Tallman, M. S.; Avivi, I.; Peled, A.; Pereg, Y.; Foley-Comer, A.; Russovsky, L.; Aharon, A.; McQueen, T.; Pemmaraju, N.; Bueso-Ramos, C. E.; Cortes, J. E.; Andreeff, M. |
| Abstract Title: | BL-8040, a peptidic CXCR4 antagonist, induces leukemia cell death and specific leukemia cell mobilization in relapsed/refractory acute myeloid leukemia patients in an ongoing phase IIA clinical trial |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243504017 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.950.950 |
| Notes: | Meeting Abstract: 950 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
